About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Multiple Sclerosis Clinical Trials | 3,711 Studies Recruiting

Clinical TrialsMultiple Sclerosis

Multiple Sclerosis Clinical Trials

Browse 3,711 clinical trials for multiple sclerosis. Find studies that match your criteria and connect with research centers.

Find trials near:

New York Los Angeles Chicago Houston Phoenix Philadelphia

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 3621-3640 of 3,711 trials

UnknownSingle Test to ARrive at MS Diagnosis. Using a Single MRI Brain Scan to Help Diagnose Multiple SclerosisThis is a pilot study (a small scale study testing procedures so that the investigators can apply this to a larger scale study).NCT02485223·Nottingham, Nottinghamshire CompletedDemographics, Clinical and Paraclinical Characteristics of Multiple Sclerosis in EgyptThe primary study aim is to depict the demographics, clinical and para clinical features of patients attending five tertiary referral multiple sclerosis (MS) centers in Egypt.NCT02970370 RecruitingNeuromodulating Cortical Regions Involved in Neurogenic Bladder in MSNeurogenic overactive bladder (NOAB), characterized by urinary frequency, urgency or urgency incontinence symptoms occurring during the storage phase of the bladder, is the most…NCT06072703·Houston, Texas

Related Searches

Data from ClinicalTrials.govTerms

CompletedUser-friendliness of a Portable Driving SimulatorThe use of simulators to retrain driving skills of patients with stroke, Parkinson's disease (PD), or multiple sclerosis (MS) is very limited because of cost, space required, and…NCT03969927·Kansas City, Kansas

Active not recruitingEfficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple SclerosisThe purpose of each study is to independently measure the annualized relapse rate (ARR) with administration of frexalimab compared to a daily oral dose of teriflunomide in male…NCT06141473·Birmingham, Alabama and 381 others

CompletedVisual (Path)Ways in Multiple Sclerosis - Part IIMultiple sclerosis (MS) is an inflammatory demyelinating and degenerative disease of the central nervous system. The mechanisms of neuro-axonal loss remain incompletely elucidated.NCT06776224·Lille

CompletedOptical Coherence Tomography in Multiple Sclerosis PatientsTo evaluate the ability of different spectral domain optical coherence tomography (OCT) devices, as well as different acquisition and analysis packages, to detect disease…NCT01774123·Cleveland, Ohio

Not yet recruitingImmune System Effects in Children Born to Women With Multiple Sclerosis Treated With Monoclonal Antibody Therapy During PregnancyThe goal of this observational study is to learn about consequences for the child when the mother is treated with rituximab (or other monoclonal CD-20 antibodies) before or during…NCT07149662·Stockholm

CompletedSerum Neurofilaments and GFAP in Atypical Multiple SclerosisIdiopathic inflammatory disorders of the central nervous system include various disorders of which multiple sclerosis is the most common.NCT04201470·Montpellier

CompletedLaughter Therapy Effects on Mood, Stress and Self-efficacy in People With Neurological Diseases.This is a prospective investigation of the effects of Laughter therapy (LT) on perceived stress, self-efficacy, mood and other wellness measures in people with the following…NCT02750982·Kirkland, Washington

CompletedComparison of Oral Molecules Preventing Relapses in Multiple SclerosisThe aim of this observational study is to compare Dimethyl fumarate (DMF) and Teriflunomide on both clinical and MRI outcomes in patients with relapsing-remitting multiple…NCT03302442·Nantes

CompletedShort and Long Term Multiple Outcomes in Persons With Multiple Sclerosis Treated by Fampridine.This prospective monocentric open label trial was realized in the Laboratory of Clinical Functional Exploration of Movement at the University Hospital of Besancon.NCT02849782·Besançon

UnknownDecision Making in Multiple Sclerosis Care Under UncertaintyThe main objectives of this study are: i) To determine patient-level, physician-level and health system factors influencing therapeutic decisions in multiple sclerosis (MS) care…NCT04035720·Toronto, Ontario

CompletedAn Observational, Retrospective, UK & Ireland Audit of Patient Adherence to Rebif® Injections Using the RebiSmart™ Injection DeviceThis is an observational, retrospective, UK \& Ireland audit measuring patient adherence to Rebif® injections with the RebiSmart™ injection device.NCT01601080·Merck KGaA Communication Center For Recruiting Locations

UnknownL Test in Multiple SclerosisMultiple Sclerosis (MS), a chronic inflammatory disease of the central nervous system, is a disease characterized by myelin, oligodendrocyte and axon damage \[1\].NCT05325359·Elâzığ

UnknownVirtual Reality for Upper Limb Rehabilitation in Multiple SclerosisThis study is aimed to test the efficacy and feasibility of an immersive virtual reality (VR) rehabilitation programs to improve upper-limb motor functions in 24 patients with…NCT04027491·Monserrato, Cagliari

CompletedTelehealth Pain Self-Management for Employed AdultsThe E-TIPS trial will evaluate an evidence-based, telehealth pain self-management intervention compared to standard care (a waitlist) for chronic pain in adults with physical…NCT04248725·Seattle, Washington

CompletedCanadian Avonex PEN Productivity StudyThis study is primarily designed to evaluate the impact of AVONEX PEN autoinjector on work capacity of participants with multiple sclerosis (MS) starting on this device.NCT01489748·Burlington, Ontario

TerminatedSafety and Efficacy of Melatonin in Patients With Multiple Progressive Primary SclerosisPhase I / II randomized, double-blind, placebo-controlled clinical trial to evaluate the safety and efficacy of melatonin administration combined with ocrelizumab in patients with…NCT03540485·Seville, Seville and 2 others

TerminatedA Study of Allogeneic Human UC-MSC and Liberation Therapy (When Associated With CCSVI) in Patients With RRMSSTUDY OBJECTIVES: Primary Objective: Assessment of treatment safety based on incidence of any treatment emergent/treatment associated adverse events prior to discharge and at 1…NCT02418325·San Fernando, Trinidad

PreviousPage 182 of 186Next